Non-syndromic adult-onset rod-cone dystrophy.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 42627262.
- Also identified by DOI 10.1097/IAE.0000000000004979.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study is to characterize phenotypes and genotypes of non-syndromic adult-onset rod-cone dystrophy (RCD) in the United Arab Emirates (UAE). Retrospective series of consecutive Emirati patients referred to the Ocular Genetics Service of Cleveland Clinic Abu Dhabi (2016-2023, inclusive) who were diagnosed with non-syndromic RCD after childhood (symptomatic at or after 16 years old) and for whom a molecular diagnosis was made after diagnostic genetic testing guided by clinical phenotype (single gene, next-generation panel, or exome sequencing). Twenty-four cases (15 male; 19 families) were identified. Autosomal recessive typical RCD was most common (17/19 families, 89%), related to homozygous variants in PCARE (8), EYS (3), AGBL5 (3), and CYP4V2 (1). Atypical early macular involvement was noted in seven unrelated cases; identified genes were CDHR1 (5) and CERKL (2). Autosomal dominant RCD was noted in two cases, related to TOPORS and PRPF31. Regarding PCARE-related disease, 7/8 cases (3/4 families) harbored the same homozygous pathogenic variant (c.2967del; p.Val990Trpfs*45). There were no other recurrent variants among families. PCARE: c.2967del; p.Val990Trpfs*45 likely represents founder effect. Atypical early macular involvement suggests variants in CDHR1 or, less commonly, CERKL. While autosomal recessive cause predominates, autosomal dominant cause can occur.